Natarajan Sethuraman - President, Research & Develop. at Entrada Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President, Research & Develop.
Issuer Symbol
TRDA on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Natarajan Sethuraman since 10 Mar 2025

Holdings reported by Natarajan Sethuraman for Entrada Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 242,224 $2,847,682 $11.76 03 Mar 2026 Direct
Stock Option (Right to Buy) 83,200 01 Mar 2026 Direct Common Stock

Transactions reported by Natarajan Sethuraman for Entrada Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.